BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26993600)

  • 1. Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma models.
    Lee HL; Park MH; Song JK; Jung YY; Kim Y; Kim KB; Hwang DY; Yoon do Y; Song MJ; Han SB; Hong JT
    Oncotarget; 2016 Apr; 7(17):23425-38. PubMed ID: 26993600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma Model.
    Son DJ; Jung YY; Park MH; Lee HL; Song MJ; Yoo HS; Hwang DY; Han SB; Hong JT
    Neoplasia; 2017 Jul; 19(7):537-548. PubMed ID: 28587956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation.
    Kaluzki I; Hrgovic I; Hailemariam-Jahn T; Doll M; Kleemann J; Valesky EM; Kippenberger S; Kaufmann R; Zoeller N; Meissner M
    Tumour Biol; 2016 Oct; 37(10):13627-13635. PubMed ID: 27468725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiinflammatory properties of a peptide derived from interleukin-4.
    Klementiev B; Enevoldsen MN; Li S; Carlsson R; Liu Y; Issazadeh-Navikas S; Bock E; Berezin V
    Cytokine; 2013 Oct; 64(1):112-21. PubMed ID: 23972727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between genes encoding components of the IL-4/IL-4 receptor pathway and dermatitis in children.
    Hussein YM; Shalaby SM; Nassar A; Alzahrani SS; Alharbi AS; Nouh M
    Gene; 2014 Jul; 545(2):276-81. PubMed ID: 24742632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of IL-4R enhances proliferation and invasion of hepatocellular carcinoma cells.
    Guo C; Ouyang Y; Cai J; Xiong L; Chen Y; Zeng X; Liu A
    Int J Biol Markers; 2017 Oct; 32(4):e384-e390. PubMed ID: 28665449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
    Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
    Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The leukemia inhibitory factor (LIF) and p21 mediate the TGFβ tumor suppressive effects in human cutaneous melanoma.
    Humbert L; Ghozlan M; Canaff L; Tian J; Lebrun JJ
    BMC Cancer; 2015 Mar; 15():200. PubMed ID: 25885043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
    Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
    Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ARHGAP24 inhibits cell proliferation and cell cycle progression and induces apoptosis of lung cancer via a STAT6-WWP2-p27 axis.
    Wang L; Shen S; Xiao H; Ding F; Wang M; Li G; Hu F
    Carcinogenesis; 2020 Jul; 41(5):711-721. PubMed ID: 31430374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.
    Bai M; Zhang M; Long F; Yu N; Zeng A; Zhao R
    Oncol Rep; 2017 May; 37(5):2702-2710. PubMed ID: 28358423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 blocks M-CSF-dependent macrophage proliferation by inducing p21Waf1 in a STAT6-dependent way.
    Arpa L; Valledor AF; Lloberas J; Celada A
    Eur J Immunol; 2009 Feb; 39(2):514-26. PubMed ID: 19130475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced interleukin-4 receptor α expression on CD8+ T cells correlates with higher quality anti-viral immunity.
    Wijesundara DK; Tscharke DC; Jackson RJ; Ranasinghe C
    PLoS One; 2013; 8(1):e55788. PubMed ID: 23383283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stat6 Promotes Intestinal Tumorigenesis in a Mouse Model of Adenomatous Polyposis by Expansion of MDSCs and Inhibition of Cytotoxic CD8 Response.
    Jayakumar A; Bothwell ALM
    Neoplasia; 2017 Aug; 19(8):595-605. PubMed ID: 28654863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.
    Gorospe M; Cirielli C; Wang X; Seth P; Capogrossi MC; Holbrook NJ
    Oncogene; 1997 Feb; 14(8):929-35. PubMed ID: 9050992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA against transcription factor STAT6 inhibits allergic airway inflammation and hyperreactivity in mice.
    Darcan-Nicolaisen Y; Meinicke H; Fels G; Hegend O; Haberland A; Kühl A; Loddenkemper C; Witzenrath M; Kube S; Henke W; Hamelmann E
    J Immunol; 2009 Jun; 182(12):7501-8. PubMed ID: 19494273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 receptor α in non-lipid rafts is the target molecule of strictinin in inhibiting STAT6 activation.
    Kim YH; Ninomiya Y; Yamashita S; Kumazoe M; Huang Y; Nakahara K; Won YS; Murata M; Fujimura Y; Yamada K; Tachibana H
    Biochem Biophys Res Commun; 2014 Jul; 450(1):824-30. PubMed ID: 24960198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
    Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
    BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renalase Expression by Melanoma and Tumor-Associated Macrophages Promotes Tumor Growth through a STAT3-Mediated Mechanism.
    Hollander L; Guo X; Velazquez H; Chang J; Safirstein R; Kluger H; Cha C; Desir GV
    Cancer Res; 2016 Jul; 76(13):3884-94. PubMed ID: 27197188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.